| Title |
Weight Loss During Intrauterine Progestin Treatment for Obesity-associated Atypical Hyperplasia and Early-Stage Cancer of The EndometriumProgestin and Weight Loss For Endometrial Neoplasia
|
|---|---|
| Published in |
Cancer Prevention Research, August 2021
|
| DOI | 10.1158/1940-6207.capr-21-0229 |
| Pubmed ID | |
| Authors |
Chloe E. Barr, Neil A.J. Ryan, A.E. Derbyshire, Y. Louise Wan, Michelle L. MacKintosh, Rhona J. McVey, James Bolton, Cheryl Fitzgerald, Dina Awad, Richard J. Slade, Akheel A. Syed, Basil J. Ammori, Emma J. Crosbie |
X Demographics
The data shown below were collected from the profiles of 54 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 31 | 57% |
| United States | 7 | 13% |
| Australia | 2 | 4% |
| Brazil | 1 | 2% |
| Spain | 1 | 2% |
| Canada | 1 | 2% |
| Unknown | 11 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 31 | 57% |
| Scientists | 12 | 22% |
| Practitioners (doctors, other healthcare professionals) | 11 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 41 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 6 | 15% |
| Other | 3 | 7% |
| Student > Master | 3 | 7% |
| Student > Bachelor | 2 | 5% |
| Unspecified | 2 | 5% |
| Other | 3 | 7% |
| Unknown | 22 | 54% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 15% |
| Unspecified | 2 | 5% |
| Biochemistry, Genetics and Molecular Biology | 2 | 5% |
| Arts and Humanities | 1 | 2% |
| Nursing and Health Professions | 1 | 2% |
| Other | 5 | 12% |
| Unknown | 24 | 59% |
Attention Score in Context
This research output has an Altmetric Attention Score of 39. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2022.
All research outputs
#1,042,807
of 25,364,603 outputs
Outputs from Cancer Prevention Research
#114
of 1,448 outputs
Outputs of similar age
#25,264
of 437,670 outputs
Outputs of similar age from Cancer Prevention Research
#4
of 20 outputs
Altmetric has tracked 25,364,603 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,448 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.7. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,670 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.